Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $102.7300 (-5.58%) ($102.5900 - $106.7000) on Wed. Jan. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.88% (three month average) | RSI | 48 | Latest Price | $102.7300(-5.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.8% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(46%) SPLV(36%) VYM(34%) XLP(33%) DIA(32%) | Factors Impacting ABBV price | ABBV will decline at least -0.94% in a week (0% probabilities). VIXM(-24%) UUP(-10%) VXX(-4%) IGOV(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.94% (StdDev 1.88%) | Hourly BBV | -1.7 () | Intraday Trend | -3.3% | | | |
|
Resistance Level | $108.64 | 5 Day Moving Average | $108.83(-5.61%) | 10 Day Moving Average | $110.23(-6.8%) | 20 Day Moving Average | $108.64(-5.44%) | To recent high | -8.8% | To recent low | 27.6% | Market Cap | $181.245b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |